Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation

Completed · Not applicable · Has a placebo group

Conditions studied: Kidney Cancer, Leukemia, Lymphoma, Neuroblastoma, Oral Complications, Sarcoma

In brief

RATIONALE: Traumeel® S (a mouth rinse) may be effective in preventing or decreasing the severity of oral mucositis caused by chemotherapy in young patients who are undergoing stem cell transplantation. PURPOSE: This randomized clinical trial is studying how well Traumeel® S works in preventing or treating mucositis in young patients who are receiving chemotherapy with or without total-body irradiation before undergoing stem cell transplantation.

Key facts

Study ID
NCT00080873
Run by
Children's Oncology Group
People needed
195
Starts
2004-04-01
Expected to finish
2011-01-01
Last updated by the study team
2016-01-07

Who can join

Age: 3 and older, up to 25. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.